Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Nipah virus disease, caused by the Nipah virus, is a recently discovered zoonotic disease characterized by fever, constitutional symptoms and encephalitis, sometimes accompanied by respiratory illness.
Features include very common findings: Fever, Nausea and vomiting, Anorexia, and Headache and others; and common findings: Seizure, Sudden, brief involuntary muscle jerks (myoclonus), Tremor, and Vertigo and others. 17 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Personality changes, Seizure, Sudden, brief involuntary muscle jerks (myoclonus) |
Biomarker and diagnostic research for Nipah virus disease has been reported in the published literature.
Phenotype severity distribution: 7 very common features, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Nipah virus disease.
118 publications have been identified in PubMed for Nipah virus disease. Research spans Review / Meta-Analysis (41%), Basic Science / Preclinical (30%), and Epidemiology / Natural History (12%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 47 | 41% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 4:48 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Nipah virus disease
Digestive system |
2 |
Nausea and vomiting, Anorexia |
Metabolism | 1 | Fever |
Lungs and breathing | 1 | Respiratory distress |
Ears | 1 | Vertigo |
Muscles | 1 | Myalgia |
35 |
30% |
Disease patterns and progression | 14 | 12% |
New treatment approaches | 6 | 5% |
Testing and diagnosis research | 5 | 4% |
Other research | 4 | 3% |
Patient case studies | 3 | 3% |
Clinical study results | 2 | 2% |
Nelwan EJ (2026). [PMID: 41978305](https://pubmed.ncbi.nlm.nih.gov/41978305/). *Acta Med Indones*. [Review / Meta-Analysis]
Aquib WR (2026). [PMID: 41716716](https://pubmed.ncbi.nlm.nih.gov/41716716/). *The Lancet regional health. Southeast Asia*. [Gene Therapy / Novel Therapeutics]
Chowdhury KIA (2026). [PMID: 41926155](https://pubmed.ncbi.nlm.nih.gov/41926155/). *JMIR Form Res*. [Epidemiology / Natural History]
Kusuma IY (2026). [PMID: 42018472](https://pubmed.ncbi.nlm.nih.gov/42018472/). *Infect Dis (Lond)*. [Review / Meta-Analysis]
Moon SY (2026). [PMID: 41601000](https://pubmed.ncbi.nlm.nih.gov/41601000/). *Vaccines*. [Basic Science / Preclinical]
Pan K (2026). [PMID: 41935612](https://pubmed.ncbi.nlm.nih.gov/41935612/). *International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases*. [Epidemiology / Natural History]
Rahman MM (2026). [PMID: 41817188](https://pubmed.ncbi.nlm.nih.gov/41817188/). *Microbiol Spectr*. [Clinical Trial Publication]
Wang Y (2026). [PMID: 41459801](https://pubmed.ncbi.nlm.nih.gov/41459801/). *Emerging microbes & infections*. [Gene Therapy / Novel Therapeutics]
Bansal A (2026). [PMID: 41519823](https://pubmed.ncbi.nlm.nih.gov/41519823/). *Systematic reviews*. [Basic Science / Preclinical]
Hassan MZ (2026). [PMID: 41592581](https://pubmed.ncbi.nlm.nih.gov/41592581/). *The Lancet. Microbe*. [Review / Meta-Analysis]